(Q40017147)

16 September 2017

title

PML enhances the regulation of p53 by CK1 in response to DNA damage (English)

1 reference

16 September 2017

0 references

O Alsheich-Bartok

1

1 reference

16 September 2017

S Haupt

2

1 reference

16 September 2017

I Alkalay-Snir

3

1 reference

16 September 2017

S Saito

4

1 reference

16 September 2017

E Appella

5

1 reference

16 September 2017

Y Haupt

6

1 reference

16 September 2017

language of work or name

English

0 references

publication date

4 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

27

1 reference

16 September 2017

issue

26

1 reference

16 September 2017

page(s)

3653-3661

1 reference

Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

PML is a direct p53 target that modulates p53 effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Loss of the tumor suppressor PML in human cancers of multiple histologic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Budding and fission yeast casein kinase I isoforms have dual-specificity protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

The casein kinase 1 family: participation in multiple cellular processes in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

The complexity of p53 stabilization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

MDMX: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Casein kinase I delta (CKIdelta) is involved in lymphocyte physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Crystal structure of a conformation-selective casein kinase-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

The p53 response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Phosphorylation site interdependence of human p53 post-translational modifications in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Molecular mechanism of the interaction between MDM2 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Identification of a tumour suppressor network opposing nuclear Akt function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Role of PML in cell growth and the retinoic acid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

Nuclear bodies and compartments: functional roles and cellular signalling in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

7 January 2021

Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

7 January 2021

Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

7 January 2021

p53 De-ubiquitination: at the edge between life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1211036

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1211036

1 reference

Dimensions Publication ID

16 September 2017

1014767616

0 references

1 reference